Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gepotidacin versus nitrofurantoin for uncomplicated urinary tract infection in adolescent and adult females
2020-000553-27Phase 3Completed
- Sponsor
- GSK
- Start
- Apr 2020
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in urinary tract infection (UTI) and acute cystitis comparing Gepotidacin arm with Nitrofurantoin arm (2 arms). Primary endpoint: Therapeutic response at test-of-cure. Started Apr 2020; status: completed.
02
Drugs
gepotidacinnitrofurantoin
03
Conditions
urinary tract infection (UTI)acute cystitis
Beyond the preview
Go deeper on 2020-000553-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-000553-27.